References

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

10.1002/art.33379 · ExternalCitation · doi-reference

Dermatomyositis: focus on cutaneous features, etiopathogenetic mechanisms and their implications for treatment

10.1007/s00281-025-01054-9 · ExternalCitation · doi-reference

Cutaneous manifestations in dermatomyositis: key clinical and serological features-a comprehensive review

10.1007/s12016-015-8496-5 · ExternalCitation · doi-reference

Autoantibody markers of increased risk of Malignancy in patients with dermatomyositis

10.1007/s12016-022-08922-4 · ExternalCitation · doi-reference

Cancer risk in dermatomyositis: a meta-analysis of cohort studies

10.1007/s40257-015-0120-1 · ExternalCitation · doi-reference

Dermatomyositis: clinical features and pathogenesis

10.1016/j.jaad.2019.06.1309 · ExternalCitation · doi-reference

Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes

10.1016/j.nmd.2019.09.014 · ExternalCitation · doi-reference

Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies

10.1016/j.semarthrit.2024.152619 · ExternalCitation · doi-reference

Autoantibodies as biomarkers of cancer risk in dermatomyositis

10.1016/j.xjidi.2026.100460 · ExternalCitation · doi-reference

Dermatomyositis

10.1016/s0190-9622(98)70263-4 · ExternalCitation · doi-reference

International guideline for idiopathic inflammatory myopathy-associated cancer screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

10.1038/s41584-024-01111-x · ExternalCitation · doi-reference

Polymyositis and dermatomyositis associated with Malignancy: a 30-year retrospective study

10.1046/j.1365-4362.2002.01648.x · ExternalCitation · doi-reference

Inflammatory muscle diseases

10.1056/nejmra1402225 · ExternalCitation · doi-reference

Janus kinase inhibitor for anti-transcription intermediary factor 1-γ positive cancer-associated dermatomyositis

10.1093/bjd/ljad396 · ExternalCitation · doi-reference

Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients

10.1093/rheumatology/keae629 · ExternalCitation · doi-reference

Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen

10.1093/rheumatology/kez572 · ExternalCitation · doi-reference

Robot-assisted surgery for rectal cancer with tumor-associated dermatomyositis during preoperative chemotherapy: a case report and literature review

10.1097/md.0000000000043758 · ExternalCitation · doi-reference

Paraneoplastic dermatoses associated with gynecologic and breast Malignancies

10.1097/ogx.0b013e3181efb12a · ExternalCitation · doi-reference

Dermatomyositis and Malignancy

10.1111/1523-1747.ep12356956 · ExternalCitation · doi-reference

Using autoantibody signatures to define cancer risk in dermatomyositis

10.1172/jci156025 · ExternalCitation · doi-reference

Risk of Malignancy in dermatomyositis and polymyositis

10.1177/1203475416665601 · ExternalCitation · doi-reference

Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study

10.1186/s13075-017-1469-8 · ExternalCitation · doi-reference

Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive study

10.1186/s13075-025-03662-0 · ExternalCitation · doi-reference

Factors predicting Malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis

10.1371/journal.pone.0094128 · ExternalCitation · doi-reference

The polymorphous spectrum of dermatomyositis: classic features, newly described skin lesions, and rare variants

10.1684/ejd.2020.3761 · ExternalCitation · doi-reference

A case in which breast cancer developed at the same time as dermatomyositis, and the onset of new cancer was able to be predicted by the exacerbating skin symptoms and parallel increase in the anti-TIF1-γ antibody levels

10.2169/internalmedicine.0569-22 · ExternalCitation · doi-reference

Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer

10.3389/fimmu.2017.00992 · ExternalCitation · doi-reference

Dermatomyositis following resection of thyroid and breast cancer: a case report and literature review

10.3389/fonc.2025.1474481 · ExternalCitation · doi-reference

Risk, risk factors, and screening of Malignancies in dermatomyositis: current status and future perspectives

10.3389/fonc.2025.1503140 · ExternalCitation · doi-reference

A case of pathological complete response and resolution of dermatomyositis following neoadjuvant chemotherapy in HER2-positive early breast cancer

10.3390/curroncol28030182 · ExternalCitation · doi-reference

Rare diagnosis of locally advanced triple-negative breast cancer with paraneoplastic dermatomyositis: a case report and literature review

10.3892/ol.2025.15055 · ExternalCitation · doi-reference

Increased levels of soluble programmed death ligand 1 associate with Malignancy in patients with dermatomyositis

10.3899/jrheum.170544 · ExternalCitation · doi-reference